We have located links that may give you full text access.
Genetic factors associated with acquired phenotypic drug resistance and its compensatory evolution during tuberculosis treatment.
Clinical Microbiology and Infection 2024 January 28
OBJECTIVES: We elucidated the factors, evolution, and compensation of antimicrobial resistance (AMR) in Mycobacterium tuberculosis (MTB) isolates under dual pressure from the intra-host environment and anti-tuberculosis (anti-TB) drugs.
METHODS: This retrospective case-control study included 337 patients with pulmonary tuberculosis from 15 clinics in Tianjin, China, with phenotypic drug susceptibility testing (DST) results available for at least two time points between January 1, 2009 and December 31, 2016. Patients in the case group exhibited acquired AMR to isoniazid (INH) and/or rifampicin (RIF), while those in the control group lacked acquired AMR. Whole-genome sequencing (WGS) was conducted on 149 serial longitudinal MTB isolates from 46 patients who acquired or reversed phenotypic INH/RIF-resistance during treatment. The genetic basis, associated factors, and intra-host evolution of acquired phenotypic INH/RIF-resistance were elucidated using a combined analysis.
RESULTS: Anti-TB interruption duration ≥30 d showed association with acquired phenotypic INH/RIF resistance (aOR=2·2, 95%CI: 1·0-5·1) and new rpoB mutations (P = 0·024). MTB evolution was 1·2 (95% CI: 1·02-1·38) single nucleotide polymorphisms per genome per year under dual pressure from the intra-host environment and anti-TB drugs. AMR-associated mutations occurred before phenotypic AMR appearance in cases with acquired phenotypic INH (10/16) and RIF (9/22) resistances.
CONCLUSIONS: Compensatory evolution may promote the fixation of INH/RIF-resistance mutations and affect phenotypic AMR. TB treatment should be adjusted based on gene sequencing results, especially in persistent culture positivity during treatment, which highlight the clinical importance of WGS in identifying reinfection and AMR acquisition before phenotypic DST.
METHODS: This retrospective case-control study included 337 patients with pulmonary tuberculosis from 15 clinics in Tianjin, China, with phenotypic drug susceptibility testing (DST) results available for at least two time points between January 1, 2009 and December 31, 2016. Patients in the case group exhibited acquired AMR to isoniazid (INH) and/or rifampicin (RIF), while those in the control group lacked acquired AMR. Whole-genome sequencing (WGS) was conducted on 149 serial longitudinal MTB isolates from 46 patients who acquired or reversed phenotypic INH/RIF-resistance during treatment. The genetic basis, associated factors, and intra-host evolution of acquired phenotypic INH/RIF-resistance were elucidated using a combined analysis.
RESULTS: Anti-TB interruption duration ≥30 d showed association with acquired phenotypic INH/RIF resistance (aOR=2·2, 95%CI: 1·0-5·1) and new rpoB mutations (P = 0·024). MTB evolution was 1·2 (95% CI: 1·02-1·38) single nucleotide polymorphisms per genome per year under dual pressure from the intra-host environment and anti-TB drugs. AMR-associated mutations occurred before phenotypic AMR appearance in cases with acquired phenotypic INH (10/16) and RIF (9/22) resistances.
CONCLUSIONS: Compensatory evolution may promote the fixation of INH/RIF-resistance mutations and affect phenotypic AMR. TB treatment should be adjusted based on gene sequencing results, especially in persistent culture positivity during treatment, which highlight the clinical importance of WGS in identifying reinfection and AMR acquisition before phenotypic DST.
Full text links
Related Resources
Trending Papers
A Guide to the Use of Vasopressors and Inotropes for Patients in Shock.Journal of Intensive Care Medicine 2024 April 14
Prevention and treatment of ischaemic and haemorrhagic stroke in people with diabetes mellitus: a focus on glucose control and comorbidities.Diabetologia 2024 April 17
British Society for Rheumatology guideline on management of adult and juvenile onset Sjögren disease.Rheumatology 2024 April 17
Diagnosis and Management of Cardiac Sarcoidosis: A Scientific Statement From the American Heart Association.Circulation 2024 April 19
Albumin: a comprehensive review and practical guideline for clinical use.European Journal of Clinical Pharmacology 2024 April 13
Eosinophilic Esophagitis: Clinical Pearls for Primary Care Providers and Gastroenterologists.Mayo Clinic Proceedings 2024 April
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app